One year follow-up and HBV RNA / HBcrAg analysis in the REP 301 Trial: REP 2139 and pegylated interferon alpha-2a in Caucasian patients with chronic HBV / HDV co-infection
Bazinet, M, Pantea, V, Cebotarescu, V, Cojuhari, L, Jimbei, P, Krawczyk, A, Vaillant, A
Published in Journal of hepatology (2017)
Published in Journal of hepatology (2017)
Get full text
Journal Article
Update on safety and efficacy in the REP 401 protocol: REP 2139-Mg or REP 2165-Mg used in combination with tenofovir disoproxil fumarate and pegylated Interferon alpha-2a in treatment naïve caucasian patients with chronic HBeAg negative HBV infection
Bazinet, M, Pantea, V, Placinta, G, Moscalu, I, Cebotarescu, V, Cojuhari, L, Jimbei, P, Iarovoi, L, Smesnoi, V, Musteata, T, Jucov, A, Krawczyk, A, Vaillant, A
Published in Journal of hepatology (2017)
Published in Journal of hepatology (2017)
Get full text
Journal Article
Update on the Safety and Efficacy of REP 2139 Monotherapy and Subsequent Combination Therapy with Pegylated Interferon Alpha-2A in Caucasian Patients with Chronic HBV/HDV Co-Infection
Bazinet, M, Pantea, V, Cebotarescu, V, Cojuhari, L, Jimbei, P, Albrecht, J, Schmid, P, Krawczyk, A, Karimzadeh, H, Roggendorf, M, Vaillant, A
Published in Journal of hepatology (2016)
Published in Journal of hepatology (2016)
Get full text
Journal Article
Establishment of persistent functional remission of HBV and HDV infection following REP 2139 and pegylated interferon alpha 2a therapy in patients with chronic HBV/HDV co-infection: 18 month follow-up results from the REP 301-LTF study
Bazinet, M., Pantea, V., Cebotarescu, V., Cojuhari, L., Jimbei, P., Vaillant, A.
Published in Journal of hepatology (01.04.2018)
Published in Journal of hepatology (01.04.2018)
Get full text
Journal Article
FRI-326 - Establishment of persistent functional remission of HBV and HDV infection following REP 2139 and pegylated interferon alpha 2a therapy in patients with chronic HBV/HDV co-infection: 18 month follow-up results from the REP 301-LTF study
Bazinet, M., Pantea, V., Cebotarescu, V., Cojuhari, L., Jimbei, P., Vaillant, A.
Published in Journal of hepatology (01.04.2018)
Published in Journal of hepatology (01.04.2018)
Get full text
Journal Article
LBP-507 - One year follow-up and HBV RNA / HBcrAg analysis in the REP 301 Trial: REP 2139 and pegylated interferon alpha-2a in Caucasian patients with chronic HBV / HDV co-infection
Bazinet, M., Pantea, V., Cebotarescu, V., Cojuhari, L., Jimbei, P., Krawczyk, A., Vaillant, A.
Published in Journal of hepatology (2017)
Published in Journal of hepatology (2017)
Get full text
Journal Article
FRI-343 - Updated follow-up analysis in the REP 401 protocol: Treatment HBeAg negative chronic hepatitis B infection with REP 2139 or REP 2165, tenofovir disoproxil fumarate and pegylated interferon alfa-2a
Vaillant, A., Bazinet, M., Pantea, V., Placinta, G., Moscalu, I., Cebotarescu, V., Cojuhari, L., Jimbei, P., Iarovoi, L., Smesnoi, V., Musteata, T., Jucov, A., Krawczyk, A.
Published in Journal of hepatology (01.04.2018)
Published in Journal of hepatology (01.04.2018)
Get full text
Journal Article
Updated follow-up analysis in the REP 401 protocol: Treatment HBeAg negative chronic hepatitis B infection with REP 2139 or REP 2165, tenofovir disoproxil fumarate and pegylated interferon alfa-2a
Vaillant, A., Bazinet, M., Pantea, V., Placinta, G., Moscalu, I., Cebotarescu, V., Cojuhari, L., Jimbei, P., Iarovoi, L., Smesnoi, V., Musteata, T., Jucov, A., Krawczyk, A.
Published in Journal of hepatology (01.04.2018)
Published in Journal of hepatology (01.04.2018)
Get full text
Journal Article
THU-154 - Update on safety and efficacy in the REP 401 protocol: REP 2139-Mg or REP 2165-Mg used in combination with tenofovir disoproxil fumarate and pegylated Interferon alpha-2a in treatment naïve caucasian patients with chronic HBeAg negative HBV infection
Bazinet, M., Pantea, V., Placinta, G., Moscalu, I., Cebotarescu, V., Cojuhari, L., Jimbei, P., Iarovoi, L., Smesnoi, V., Musteata, T., Jucov, A., Krawczyk, A., Vaillant, A.
Published in Journal of hepatology (2017)
Published in Journal of hepatology (2017)
Get full text
Journal Article
FRI-105 - Update on the Safety and Efficacy of REP 2139 Monotherapy and Subsequent Combination Therapy with Pegylated Interferon Alpha-2A in Caucasian Patients with Chronic HBV/HDV Co-Infection
Bazinet, M., Pantea, V., Cebotarescu, V., Cojuhari, L., Jimbei, P., Albrecht, J., Schmid, P., Krawczyk, A., Karimzadeh, H., Roggendorf, M., Vaillant, A.
Published in Journal of hepatology (2016)
Published in Journal of hepatology (2016)
Get full text
Journal Article